Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea

Multiple myeloma (MM) is the third most common hematologic malignancy in Korea. Historically, the incidence of MM in Korea has been lower than that in Western populations, although there is growing evidence that the incidence of MM in Asian populations, including Korea, is increasing rapidly. Despit...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Blood Res
المؤلفون الرئيسيون: Kim, Hyo Jung, Yoon, Sung-Soo, Eom, Hyeon Seok, Kim, Kihyun, Kim, Jin Seok, Lee, Je-Jung, Bang, Soo-Mee, Min, Chang-Ki, Park, Joon Seong, Lee, Jae-Hoon
التنسيق: Artigo
اللغة:Inglês
منشور في: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
الموضوعات:
Review Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4377347/
https://ncbi.nlm.nih.gov/pubmed/25830125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2015.50.1.7
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة